68Ga-NRT6020

N/A

Report date: 2026/01/27 10:54:36

NME

Base Information

Drug Name68Ga-NRT6020

Drug Alias Name68Ga-NRT6020

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionFibroblast activation protein alpha antagonistsPositron-emission tomography enhancers

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesChengdu New Radiomedicinetechnology Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu New Radiomedicinetechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A